Voya Investment Management LLC Adverum Biotechnologies, Inc. Transaction History

Voya Investment Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $29,390 - $48,620	-36,284 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.74 - $2.4 $3,918 - $5,404	-2,252 Reduced 5.84%	36,284 $64,000
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $3,926 - $6,088	424 Added 1.11%	38,536 $380,000
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $11,670 - $16,912	1,186 Added 3.21%	38,112 $413,000
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $119,624 - $251,326	11,614 Added 45.88%	36,926 $380,000
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $51,717 - $155,455	-6,063 Reduced 19.32%	25,312 $529,000
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $38,623 - $78,988	4,840 Added 18.24%	31,375 $307,000
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $23,971 - $57,214	4,682 Added 21.42%	26,535 $306,000
Q2 2019 Aug 14, 2019	BUY	$5.1 - $11.89 $8,358 - $19,487	1,639 Added 8.11%	21,853 $260,000
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $107,134 - $139,476	20,214 New	20,214 $107,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.